Blutree Orthopedic Implants
Founded in 1999, our organization stands as a pioneer in the Chinese orthopedic implant research and development sector. With over two decades of technical accumulation, we have evolved into a global titan, providing high-end medical solutions to the international market. Our CE-certified revision knee systems represent the pinnacle of surgical engineering, designed to address the most complex cases of arthroplasty failure.
Revision Total Knee Arthroplasty (rTKA) is significantly more complex than primary replacement. It requires a deep understanding of biomechanics, bone loss management, and ligamentous stability. As a global leading Revision Knee Systems factory, we provide CE-certified components that allow surgeons to navigate the challenges of bone defects (AORI Class I-III), joint line restoration, and stable implant fixation.
Modern revision systems must provide modularity. Our systems are designed with metaphyseal sleeves and cones, various stem lengths (cemented and press-fit), and different levels of constraint (from Posterior Stabilized to Constrained Condylar Knee and Hinged options). This versatility ensures that regardless of the bone quality, a stable construct can be achieved.
Interchangeable components allow for intraoperative flexibility, matching the patient's unique anatomy and bone loss profile perfectly.
Utilizing high-grade Titanium alloys and Ultra-High Molecular Weight Polyethylene (UHMWPE) for reduced wear and increased longevity.
Our manufacturing processes adhere to the strictest ISO 13485 standards, backed by clinical data and decades of surgical experience.
The future of revision knee systems lies in 3D-printed porous titanium structures that mimic human cancellous bone, promoting rapid osseointegration and long-term stability.
We are developing systems compatible with robotic-assisted surgery and AI-driven preoperative planning to enhance precision in joint line restoration.
Researching embedded sensors within the tibial tray to monitor load distribution and detect early-stage infection or loosening.
In Western markets, where the aging population is increasing the demand for second and third-stage revisions, our CE Certified systems provide a cost-effective yet high-performance alternative to traditional brands. In emerging markets, our localized support teams and registration expertise (60+ countries) ensure that hospitals have access to world-class implants with shortened lead times.
Our manufacturing hub in China leverages a massive industrial ecosystem. By integrating raw material sourcing, high-precision CNC machining, and state-of-the-art sterilization facilities in one region, we achieve unparalleled efficiency.













